AEON Biopharma, Inc. (AEON) has recorded 114 insider transactions from 15 insiders. Total insider buying volume stands at $85K, while total selling volume is $73.8M. Overall insider sentiment is bullish (75% purchases).
AEON Biopharma, Inc. (AEON) has recorded 114 insider operations, including 3 open-market purchases ($85K), 1 sales ($73.8M) and 110 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (75% purchases).
Among the most active insiders are Forth Marc (CEO), Bancroft Robert E. (CEO) & Bencich John (CFO), with respectively 10, 2, 77 transactions.
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Advanced analytics coming soon
Price impact analysis, win rates, and predictive signals are being developed.